• Nenhum resultado encontrado

[PDF] Top 20 Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?

Has 10000 "Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?" found on our website. Below are the top 20 most common "Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?".

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?

... regimen with two drugs (RFB and isoniazid), may have helped in the understanding of the drug prescription and ...together with the fact that lopinavir-ritonavir are prescribed in ... See full document

5

Re-treatment tuberculosis cases categorised as "other": are they properly managed?

Re-treatment tuberculosis cases categorised as "other": are they properly managed?

... all treatment cards should have been returned to the MPC TB registration centre at the time of this ...at the peripheral sites or within the TB registry, introducing bias if ... See full document

6

Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India.

Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India.

... MDR-TB treatment pro- gram has been described in detail in a previous publication ...Individualized treatment regimens are designed for each patient, based on drug susceptibility testing (DST) and ... See full document

7

Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study.

Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study.

... were HIV -infected. Table 1 compares characteristics of partic- ipants at the time of enrolment by HIV ...status. The mean age of HIV-uninfected was ...of HIV- infected ...among ... See full document

10

Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India.

Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India.

... patients with symptoms suggestive of TB or any patient referred to the clinic with MDR-TB suspicion were screened with two sputum samples for acid-fast bacilli (AFB) by sputum smear ... See full document

9

Effectiveness of Highly Active Antiretroviral Therapy (HAART) Used Concomitantly With Rifampicin in Patients with Tuberculosis and AIDS

Effectiveness of Highly Active Antiretroviral Therapy (HAART) Used Concomitantly With Rifampicin in Patients with Tuberculosis and AIDS

... evaluated the effectiveness of two HAART regimens concomitant to rifampicin based tuberculosis (TB) ...Patients with TB/HIV diagnosis followed at the TB program between June 2000 ... See full document

5

Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease.

Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease.

... evaluate the efficacy of three different ART ...of the three study groups according to the baseline occurrence of an AIDS-defining disease is observational and hence is subject to covariates ... See full document

7

Enteroparasitosis Prevalence and Parasitism Influence in Clinical Outcomes of Tuberculosis Patients with or without HIV Co-Infection in a Reference Hospital in Rio de Janeiro (2000-2006)

Enteroparasitosis Prevalence and Parasitism Influence in Clinical Outcomes of Tuberculosis Patients with or without HIV Co-Infection in a Reference Hospital in Rio de Janeiro (2000-2006)

... for the study were: demographical (sex, age, occupation, and education), clinical (tuberculosis clinical presentation, treatment outcomes), and laboratorial (white blood cell and eosinophils ... See full document

6

Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho.

Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho.

... during the course of routine clinical ...negative or contaminated baseline cultures resulting from issues at the national laboratory, and were excluded from the ...study. The Lesotho ... See full document

7

The impact of isoniazid resistance on the treatment outcomes of smear positive re-treatment tuberculosis patients in the state of Andhra Pradesh, India.

The impact of isoniazid resistance on the treatment outcomes of smear positive re-treatment tuberculosis patients in the state of Andhra Pradesh, India.

... cases are collected in peripheral health institutions and transported to a centrally located intermediate reference laboratory (IRL) which is accredited nationally to perform ...Patients with confirmed ... See full document

6

Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru.

Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru.

... mono-resistance treatment outcomes have been a topic of debate due to conflict- ing ...compatible with prior reports demonstrating that isoniazid mono-resistant cases are at a higher risk for ... See full document

11

The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks.

The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks.

... and the presence of SNPs at codon 516 in the rpoB gene (Table ...in the RFB MICs, from ...for the mutant isolates was observed. The corresponding MIC shift for RIF was from ...findings, ... See full document

4

Tuberculosis, before and after Antiretroviral Therapy among HIV-Infected Children in Nigeria: What Are the Risk Factors?

Tuberculosis, before and after Antiretroviral Therapy among HIV-Infected Children in Nigeria: What Are the Risk Factors?

... accordance with the clinical and age-dependent immunological criteria of World Health Organization (WHO) guidelines of 2006 and 2010 and as adopted in the document of the Nigerian National ... See full document

19

Playing for better or for worse? Health and Social outcomes with electronic gaming

Playing for better or for worse? Health and Social outcomes with electronic gaming

... associated with high intrinsic motivation. For example, the feedback that comes from achieving positive results in a game (either playing with others or just trying to improve one’s own score) ... See full document

24

Factors associated with nonadherence of tuberculosis treatment in the state of Paraná

Factors associated with nonadherence of tuberculosis treatment in the state of Paraná

... DOT are considered the cases where the supervision of medication occurred in at least 24 doses in the initial phase (in the first two months) and 48 doses in the maintenance ... See full document

7

Systematic review of the performance of rapid rifampicin resistance testing for drug-resistant tuberculosis.

Systematic review of the performance of rapid rifampicin resistance testing for drug-resistant tuberculosis.

... rapid rifampicin resistance test result in a TB patient, results from conventional drug sensitivity testing (DST) via solid or liquid culture will likely play a large role in identifying the ideal ... See full document

11

The experience of surgical treatment of patients with pulmonary extensively resistant tuberculosis

The experience of surgical treatment of patients with pulmonary extensively resistant tuberculosis

... For the last time tendency for growing of drug resistant tuberculosis including extensively drug resistant TB is marked all over the ...constitute the specific processes with ... See full document

4

Rates of anti-tuberculosis drug resistance in Kampala-Uganda are low and not associated with HIV infection.

Rates of anti-tuberculosis drug resistance in Kampala-Uganda are low and not associated with HIV infection.

... to the National TB/Leprosy Programme ...by the sample size of 483 new patients, based on the requirement to measure in this group an MDR prevalence of ...1.4% with an upper boundary of ... See full document

7

Designing and analyzing clinical trials with composite outcomes: consideration of possible treatment differences between the individual outcomes.

Designing and analyzing clinical trials with composite outcomes: consideration of possible treatment differences between the individual outcomes.

... possible treatment differences within a composite outcome in the trial pre-specified statistical ...define the assumptions of the models that will be used and suggest alternative models to be ... See full document

6

Impact of tuberculosis treatment length and adherence under different transmission intensities

Impact of tuberculosis treatment length and adherence under different transmission intensities

... among the various studies is the conviction that shorter treat- ment regimens are likely to be associated with increased compliance, and this duality is likely to reduce TB ...from the ... See full document

35

Show all 10000 documents...